The estimated Net Worth of Keith R Leonard is at least $4.13 Milion dollars as of 25 April 2024. Mr. Leonard owns over 569 units of Unity Biotechnology Inc stock worth over $2,248 and over the last 9 years he sold UBX stock worth over $854,000. In addition, he makes $3,270,820 as Chairman of the Board at Unity Biotechnology Inc.
Keith has made over 16 trades of the Unity Biotechnology Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 569 units of UBX stock worth $797 on 25 April 2024.
The largest trade he's ever made was buying 100,000 units of Unity Biotechnology Inc stock on 22 February 2019 worth over $250,000. On average, Keith trades about 3,590 units every 66 days since 2016. As of 25 April 2024 he still owns at least 1,606 units of Unity Biotechnology Inc stock.
You can see the complete history of Mr. Leonard stock trades at the bottom of the page.
Keith R. Leonard Jr. serves as Chairman of the Board of the Company. Mr. Leonard was a co-founder of and served as President and Chief Executive Officer of KYTHERA Biopharmaceuticals, Inc., a public biopharmaceutical company from August 2005 until its acquisition by Allergan plc, a public pharmaceutical company, in October 2015. Prior to that, Mr. Leonard held roles of increasing responsibility at Amgen Inc., a public biotechnology company, from October 1991 to November 2004, including as Senior Vice President and General Manager of Amgen Europe. Mr. Leonard currently serves on the board of directors of Sanifit Laboratories S.L., a biopharmaceutical company and Intuitive Surgical, Inc., a public medical device company. He previously served on the boards of directors of Sienna Biopharmaceuticals, a public biopharmaceutical company, Affymax, Inc., a public biotechnology company, Anacor Pharmaceuticals, Inc., a public biopharmaceutical company, and ARYx Therapeutics, Inc., a public biopharmaceutical company. Mr. Leonard was formerly an active duty officer in the United States Navy. Mr. Leonard received a B.S. in Engineering from the University of California, Los Angeles, a B.A. in History from the University of Maryland, an M.S. in Engineering from the University of California, Berkeley, and an M.B.A. from the Anderson School of Management at the University of California, Los Angeles.
As the Chairman of the Board of Unity Biotechnology Inc, the total compensation of Keith Leonard at Unity Biotechnology Inc is $3,270,820. There are no executives at Unity Biotechnology Inc getting paid more.
Keith Leonard is 58, he's been the Chairman of the Board of Unity Biotechnology Inc since 2020. There are 5 older and 17 younger executives at Unity Biotechnology Inc. The oldest executive at Unity Biotechnology Inc is David Lacey, 67, who is the Independent Director.
Keith's mailing address filed with the SEC is 1020, Kifer Road, Sunnyvale, Santa Clara County, California, 95086, United States.
Over the last 7 years, insiders at Unity Biotechnology Inc have traded over $9,012,473 worth of Unity Biotechnology Inc stock and bought 3,200 units worth $28,480 . The most active insiders traders include Kristina Burow, Robert Nelsen oraz Nathaniel E David. On average, Unity Biotechnology Inc executives and independent directors trade stock every 54 days with the average trade being worth of $65,316. The most recent stock trade was executed by Alexander Hieu Nguyen on 2 August 2024, trading 154 units of UBX stock currently worth $236.
unity biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. unity's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. more information is available at www.unitybiotechnology.com.
Unity Biotechnology Inc executives and other stock owners filed with the SEC include: